Advertisement

Lung Cancer: An Overview

  • Aisha NaseerEmail author
  • Arum Parthipun
  • Athar Haroon
  • Stephen Ellis
Chapter
  • 802 Downloads
Part of the Clinicians’ Guides to Radionuclide Hybrid Imaging book series (CGRHI)

Abstract

Lung cancer is the most common cancer worldwide with 1.8 million (1,825,000) new cases diagnosed in 2012 [1]. According to statistics from Cancer Research UK, the majority of patients diagnosed with lung cancer present with advanced stage IV disease (NSCLC—non-small cell lung cancer) or extensive disease (SCLC—small cell lung cancer).

References

  1. 1.
    Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon: International Agency for Research on Cancers; 2013.Google Scholar
  2. 2.
    NICE Clinical Guidelines, No. 121. The diagnosis and treatment of lung cancer; 2011.Google Scholar
  3. 3.
    Peto R, Lopez AD, Boreham J, et al. Mortality from smoking in developed countries 1950–2000: Indirect estimates from National Vital Statistics. Oxford University Press; 2006. ISBN 0-19-262535-7.Google Scholar
  4. 4.
    O’Reilly KM, Mclaughlin AM, Beckett WS, Sime PJ. Asbestos-related lung disease. Am Fam Physician. 2007;75(5): 683–8. PMID 17375514.Google Scholar
  5. 5.
    Detterbeck FC, Boffa DJ, Kim AW, et al. The eighth edition lung cancer stage classification. Chest 2017;151(1):193–203.Google Scholar
  6. 6.
    Nicholson SA, Beasley MB, Brambilla E, et al. Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens. Am J Surg Pathol. 2002;26(9):1184–97.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  • Aisha Naseer
    • 1
    Email author
  • Arum Parthipun
    • 2
  • Athar Haroon
    • 1
  • Stephen Ellis
    • 1
  1. 1.Barts Health NHS TrustLondonUK
  2. 2.Department of Nuclear MedicineRoyal Free London NHS Foundation TrustLondonUK

Personalised recommendations